Latest filing published 02 Oct 2026 for OCULAR THERAPEUTIX, INC., €63k.
No signal scores available.
Peter Kazuo Kaiser discloses dealings in Ocular Therapeutix, Inc to SEC (Form 4). Over a trading history stretching from 24 August 2026 to 2 October 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 2 October 2026: a transaction of €63k, in Ocular Therapeutix, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations